AdvanCell Isotopes Pty Limited

Australie


 
Quantité totale PI 14
Rang # Quantité totale PI 109 180
Note d'activité PI 2,2/5.0    20
Rang # Activité PI 41 252
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

4 2
2 0
4 2
0
 
Dernier brevet 2025 - Radiopharmaceuticals
Premier brevet 2022 - Materials and processes for gene...
Dernière marque 2022 - ALPHA 212
Première marque 2022 - ALPHA 212

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Radiopharmaceuticals. This application relates generally to prostate specific membrane antigen (...
Invention Dosage regimen for short-lived radioisotope. There is provided a method for treating cancer in a ...
Invention Materials and processes for generating radioisotopes. The present disclosure generally relates to...
Invention Radioisotope source. A layered radioisotope source for generating a medically useful dose of daug...
2023 Invention Radiopharmaceuticals. This application relates generally to prostate specific membrane antigen (P...
Invention Radiopharmaceuticals
2022 Invention Materials and processes for generating radioisotopes. The present disclosure generally relates t...
Invention Materials and processes for generating radioisotope. The present disclosure generally relates to ...
P/S Medical and pharmaceutical preparations for the treatment of cancer; medical and pharmaceutical p...
P/S Medical and pharmaceutical preparations; medical and pharmaceutical preparations containing isot...